Alan Landay to Sulfonamides
This is a "connection" page, showing publications Alan Landay has written about Sulfonamides.
Connection Strength
0.182
-
Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks. AIDS Res Hum Retroviruses. 2012 Oct; 28(10):1184-95.
Score: 0.098
-
Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL). J Leukoc Biol. 2009 Nov; 86(5):1019-21.
Score: 0.083